Product Images Zingo

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 13 images provide visual information about the product associated with Zingo NDC 61388-123 by Powder Pharmaceutical Incorporated, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Carton Label - Carton Label

Carton Label - Carton Label

This text appears to contain information about a medication in powder form for intradermal injection, specifically mentioning hydrochloride monohydrate. The medication seems to be intended for single use as it contains 12 sterile units. The text also indicates the presence of a label place on the packaging. The product's expiry date is mentioned as well.*

Device Label - Device label

Device Label - Device label

structure formula - Figure LHM Structure

structure formula - Figure LHM Structure

Figure 1a - figure1a

Figure 1a - figure1a

Figure 1b - figure1b

Figure 1b - figure1b

This text is not readable.*

Figure - figure2

Figure - figure2

Figure 3 - figure3

Figure 3 - figure3

Figure 4 - figure4

Figure 4 - figure4

Figure 5a - figure5a

Figure 5a - figure5a

This text appears to refer to a product or item that may involve sealing against the skin. It is likely related to skincare, cosmetics, or medical supplies.*

Figure 5b - figure5b

Figure 5b - figure5b

This text describes the safety configuration of a button where pressing it down against the skin raises it to a position where it can be inwardly pressed with the thumb. The button can be locked and unlocked, and it is ready to be pressed inward when unlocked.*

Figure 6 - figure6

Figure 6 - figure6

Table 1 - table1

Table 1 - table1

This text provides a comparison of the Visual Analogue Scale Score between an active group (N=345) and a placebo group (N=348) in an adult study. The adjusted mean Least Squares Means (LSM) for the active group is 16.23, with a difference in LSMs of 4.62 (SE 1.55) between the two groups. The 95% confidence interval for this difference ranges from 7.67 to 15.7. This information can be useful in evaluating the safety and efficacy of the study intervention.*

Table 2 - table2

Table 2 - table2

This text provides data from Table 2 displaying the Modified FACES Scale Score for Studies 1 and 2 in relation to Active and Placebo groups. The table includes Adjusted Mean LSM values, Difference in LSMs with their standard errors, and 95% Confidence Limits.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.